ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

The March: Cancer Centers To Plan Events In Conjunction With Sept. 26 March

April 10, 1998

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Senate Passes Budget; Broder; Fiscal 93 Great Year – Not

September 25, 1992

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011